Imaging in breast cancer: Magnetic resonance spectroscopy

Breast Cancer Research

Volumn 7, Issue 4, 2005, Pages 149-152

  Bolan, Patrick J ^a   Nelson, Michael T ^a   Yee, Douglas ^a   Garwood, Michael ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHORUS 31; PROTON;

BREAST CANCER; CANCER DIAGNOSIS; CANCER RESEARCH; CANCER THERAPY; CLINICAL PROTOCOL; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; HUMAN; IN VIVO STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATIENT MONITORING; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PROTON NUCLEAR MAGNETIC RESONANCE; QUALITY CONTROL; QUANTITATIVE ANALYSIS; RELIABILITY; REVIEW; SENSITIVITY AND SPECIFICITY; SIGNAL DETECTION;

BREAST NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; PROTONS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 21044447269     PISSN: 14655411     EISSN: None     Source Type: Journal    
DOI: 10.1186/bcr1202     Document Type: Review

References (25)

1. Daly PF, Cohen JS: Magnetic resonance spectroscopy of tumors and potential in vivo clinical applications: a review. Cancer Res 1989, 49:770-779.
2. 31P measurements of response to treatment. NMR Biomed 1998, 11:314-340.
3. Sijens PE, Wijrdeman HK, Moerland MA, Bakker CJG, Vermeulen JWAH, Luyten PR: Human breast cancer in vivo: H-1 and P-31 MR spectroscopy at 1.5 T. Radiology 1988, 169:615-620.
4. Jagannathan NR, Singh M, Govindaraju V, Raghunathan P, Choshic O, Julka PK, Rath GK: Volume localized in vivo proton MR spectroscopy of breast carcinoma: variation of water-fat ratio in patients receiving chemotherapy. NMR Biomed 1998, 11:414-422.
5. Thomas MA, Binesh N, Yue K, DeBruhl N: Volume-localized two-dimensional correlated magnetic resonance spectroscopy of human breast cancer. J Magn Reson Imaging 2001, 14:181-186.
6. Roebuck JR, Cecil KM, Schnall MD, Lenkinski RE: Human breast lesions: characterization with proton MR spectroscopy. Radiology 1998, 209:269-275.
7. 1H MRS of normal breast and breast tumors using dedicated double breast coil. J Magn Reson Imaging 1998, 8:1191-1197.
8. 1H MR spectroscopy. J Magn Reson Imaging 1999, 10:159-164.
9. Yeung DK, Cheung HS, Tse GM: Human breast lesions: characterization with contrast-enhanced in vivo proton MR spectroscopy - initial results. Radiology 2001, 220:40-46.
10. Cecil KM, Schnall MD, Siegelman ES, Lenkinski RE: The evaluation of human breast lesions with magnetic resonance imaging and proton magnetic resonance spectroscopy. Breast Cancer Res Treat 2001, 68:45-54.
11. Jagannathan NR, Kumar M, Seenu V, Coshic O, Dwivedi SN, Julka PK, Srivastava A, Rath GK: Evaluation of total choline from in vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer. Br J Cancer 2001, 84:1016-1022.
12. Mackinnon WB, Barry PA, Malycha PL, Gillett DJ, Russell P, Lean CL, Doran ST, Barraclough BH, Bilous M, Mountford CE: Fine-needle biopsy specimens of benign breast lesions distinguished from invasive cancer ex vivo with proton MR spectroscopy. Radiology 1997, 204:661-666.
13. Cheng LL, Chang W, Smith BL, Gonzalez RG: Evaluating human breast ductal carcinomas with high-resolution magic-angle spinning proton magnetic resonance spectrscopy. J Magn Reson 1998, 135:194-202.
14. Gribbestad IS, Sitter B, Lundgren S, Krane J, Axelson D: Metabolite composition in breast tumors examined by proton nuclear magnetic resonance spectroscopy. Anticancer Res 1999, 19: 1737-1746.
15. Garwood M, DelaBarre L: The return of the frequency sweep: designing adiabatic pulses for contemporary NMR. J Magn Reson 2001, 153:155-177.
16. Jacobs MA, Barker PB, Bottomley PA, Bhujwalla Z, Bluemke DA: Proton magnetic resonance spectroscopic imaging of human breast cancer: a preliminary study. J Magn Reson Imaging 2004, 19:68-75.
17. 1H MRS of breast lesions. Magn Reson Med 2002, 48:215-222.
18. 1H MR spectroscopy. Magn Reson Med 2003, 50:1134-1143.
19. Bakken IJ, Gribbestad IS, Singstad TE, Kvistad KA: External standard method for the in vivo quantification of choline-containing compounds in breast tumors by proton MR spectroscopy at 1.5 Tesla. Magn Reson Med 2001, 46:189-192.
20. Katz-Brull R, Lavin PT, Lenkinski RE: Clinical utility of proton magnetic resonance spectroscopy in characterizing breast lesions. J Natl Cancer Inst 2002, 94:1197-1203.
21. Huang W, Fisher PR, Dulaimy K, Tudorica LA, O'Hea B, Button TM: Detection of breast malignancy: diagnostic MR protocol for improved specificity. Radiology 2004, 232:585-591.
22. 1H MRS for improving diagnostic accuracy of breast MRI: preliminary results from an observer performance study at 4 Tesla. Radiology 2005, in press.
23. 1H MRS: a pilot study at 4 Tesla. Radiology 2004, 233:424-431.
24. 1H-MRS evaluation of malignant and benign breast disease. Breast 2003, 12:179-182.
25. Tse GMK, Cheung HS, Pang L-M, Chu WCW, Law BKB, Kung FYL, Yeung DKW: Characterization of lesions of the breast with proton MR spectroscopy: comparison of carcinomas, benign lesions, and phyllodes tumors. Am J Roentgenol 2003, 181:1267-1272.